Secondary analysis of a pilot RCT in adults ≥60 with new AML (77 of 100 analysed): fewer patients than oncologists expected functional decline at 6 months (15% vs 51%). Meaningful discordance was lower with UR-GOAL vs usual care (27% vs 56%).
Secondary analysisn = 77
Jensen-Battaglia et al. Patient and oncologist expectations of functional prognosis among older adults with acute myeloid leukemia